Highnoon Laboratories Limited (PSX:HINOON)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
1,115.70
-12.67 (-1.12%)
At close: Nov 11, 2025
-1.12%
Market Cap59.11B
Revenue (ttm)26.61B
Net Income (ttm)3.67B
Shares Out52.98M
EPS (ttm)69.33
PE Ratio16.09
Forward PEn/a
Dividend40.00 (3.54%)
Ex-Dividend DateApr 18, 2025
Volume14,316
Average Volume30,149
Open1,120.25
Previous Close1,128.37
Day's Range1,105.00 - 1,128.00
52-Week Range793.00 - 1,241.00
Beta-0.02
RSI43.08
Earnings DateOct 28, 2025

About Highnoon Laboratories

Highnoon Laboratories Limited, together with its subsidiaries, manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products. It offers products in various therapeutic areas, including allergy, anti-infective, cardiology, gastroenterology, metabolic, musculoskeletal, obstetrics and gynaecology, paediatrics, allergy, respiratory, and urology; and generic products under various brands. The company operates in Pakistan, Afghanistan, the United Arab Emirates, France, Kenya, Iraq, Cambodia, Tanzania, Dubai, Sudan, an... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1984
Employees 2,376
Stock Exchange Pakistan Stock Exchange
Ticker Symbol HINOON
Full Company Profile

Financial Performance

In 2024, Highnoon Laboratories's revenue was 24.63 billion, an increase of 24.60% compared to the previous year's 19.77 billion. Earnings were 3.39 billion, an increase of 38.44%.

Financial Statements

News

There is no news available yet.